Skip to main content

Irene De la Calle Fuentes

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Irene De la Calle Fuentes

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

ScreenEC, validació d'una eina de triatge no invasiu en càncer d'endometri

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Francesc Xavier Serra Marin, Josep Castellví Vives, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 99946
Reference: SLT036/24/000059
Duration: 21/12/2024 - 31/12/2026

Telemedicine-guided Patients Reported Outcome Measures (PROMs): side efects screening and early intervention to impact in quality of life of gynaecological cancer patients.

IP: Vicente Bebia Conesa
Collaborators: Maria Asuncion Perez Benavente, Francesc Xavier Serra Marin, Antonio Gil Moreno, Martina Angeles Fite, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Melissa Bradbury Lobato, Melek Denizli
Funding agency: Fundació La Marató de TV3
Funding: 96737.5
Reference: 202403-30
Duration: 28/02/2025 - 27/02/2028

Telemedicine-guided Patients Reported Outcome Measures (PROMs): side efects screening and early intervention to impact in quality of life of gynaecological cancer patients.

IP: Vicente Bebia Conesa
Collaborators: Maria Asuncion Perez Benavente, Francesc Xavier Serra Marin, Antonio Gil Moreno, Martina Angeles Fite, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Melissa Bradbury Lobato, Melek Denizli , Telemedicine-guided Patients Reported Outcome Measures (PROMs): side efects screening and early intervention to impact in qualit
Funding agency: Fundació La Marató de TV3
Funding: 96737.5
Reference: 202403-30
Duration: 28/02/2025 - 27/02/2028

Desarrollo de CEMARK-Px, un método in vitro para el diagnóstico objetivo y preciso del tipo y grado histológico del cáncer de endometrio en fluido uterino

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Lourdes Elena Salazar Huayna, Melek Denizli
Funding agency: Instituto de Salud Carlos III
Funding: 278300
Reference: DTS23/00091
Duration: 01/01/2024 - 31/12/2026

Related news

The Biomedical Research in Gynaecology group at VHIR has contributed to this international resource with endometrial cancer organoid models.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Related professionals

Belen Perez Gomez

Belen Perez Gomez

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Laura Gómez Dabó

Laura Gómez Dabó

Predoctoral researcher
Headache and Neurological Pain
Read more
Aleix Benítez Martínez

Aleix Benítez Martínez

Predoctoral researcher
Infectious Diseases
Read more
Tamara Gómez López

Tamara Gómez López

Research technician
Donation and transplantation of organs, tissues and cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.